Related references
Note: Only part of the references are listed.Triple-Negative Breast Cancer: A Review of Conventional and Advanced Therapeutic Strategies
Mauricio A. Medina et al.
INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH (2020)
GLUT1 inhibition blocks growth of RB1-positive triple negative breast cancer
Qin Wu et al.
NATURE COMMUNICATIONS (2020)
Triple-negative breast cancer molecular subtyping and treatment progress
Li Yin et al.
BREAST CANCER RESEARCH (2020)
LinkedOmics: analyzing multi-omics data within and across 32 cancer types
Suhas V. Vasaikar et al.
NUCLEIC ACIDS RESEARCH (2018)
Glucose transporters in cancer - from tumor cells to the tumor microenvironment
Pierre-Benoit Ancey et al.
FEBS JOURNAL (2018)
COEXPEDIA: exploring biomedical hypotheses via co-expressions associated with medical subject headings (MeSH)
Sunmo Yang et al.
NUCLEIC ACIDS RESEARCH (2017)
GEPIA: a web server for cancer and normal gene expression profiling and interactive analyses
Zefang Tang et al.
NUCLEIC ACIDS RESEARCH (2017)
Upregulation of SLC2 (GLUT) family genes is related to poor survival outcomes in papillary thyroid carcinoma: Analysis of data from The Cancer Genome Atlas
Young Jun Chai et al.
SURGERY (2017)
Identification and Optimization of the First Highly Selective GLUT1 Inhibitor BAY-876
Holger Siebeneicher et al.
CHEMMEDCHEM (2016)
Expression of Glut-1 and HK-II in Pancreatic Cancer and Their Impact on Prognosis and FDG Accumulation
Hai-Jing Yang et al.
TRANSLATIONAL ONCOLOGY (2016)
Upregulation of Claudin-4, CAIX and GLUT-1 in distant breast cancer metastases
Laura S. Jiwa et al.
BMC CANCER (2014)
The SLC2 (GLUT) family of membrane transporters
Mike Mueckler et al.
MOLECULAR ASPECTS OF MEDICINE (2013)
A Small-Molecule Inhibitor of Glucose Transporter 1 Downregulates Glycolysis, Induces Cell-Cycle Arrest, and Inhibits Cancer Cell Growth In Vitro and In Vivo
Yi Liu et al.
MOLECULAR CANCER THERAPEUTICS (2012)
The genomic and transcriptomic architecture of 2,000 breast tumours reveals novel subgroups
Christina Curtis et al.
NATURE (2012)
Expression of GLUT1 and GLUT3 Glucose Transporters in Endometrial and Breast Cancers
Anna Krzeslak et al.
PATHOLOGY & ONCOLOGY RESEARCH (2012)
Targeting GLUT1 and the Warburg Effect in Renal Cell Carcinoma by Chemical Synthetic Lethality
Denise A. Chan et al.
SCIENCE TRANSLATIONAL MEDICINE (2011)
Evolutionary ancestry and novel functions of the mammalian glucose transporter (GLUT) family
Amy L. Wilson-O'Brien et al.
BMC EVOLUTIONARY BIOLOGY (2010)
GLUT1 and CAIX expression profiles in breast cancer correlate with MCT1 overexpression
C. Pinheiro et al.
EJC SUPPLEMENTS (2010)
A six-gene signature predicting breast cancer lung metastasis
Thomas Landemaine et al.
CANCER RESEARCH (2008)
High-resolution genomic and expression analyses of copy number alterations in breast tumors
Peter M. Haverty et al.
GENES CHROMOSOMES & CANCER (2008)
A novel inhibitor of glucose uptake sensitizes cells to FAS-induced cell death
Tabitha E. Wood et al.
MOLECULAR CANCER THERAPEUTICS (2008)
X chromosomal abnormalities in basal-like human breast cancer
AL Richardson et al.
CANCER CELL (2006)
Different gene expression patterns in invasive lobular and ductal carcinomas of the breast
HJ Zhao et al.
MOLECULAR BIOLOGY OF THE CELL (2004)
Interactions of androgens, green tea catechins and the antiandrogen flutamide with the external glucose-binding site of the human erythrocyte glucose transporter GLUT1
RJ Naftalin et al.
BRITISH JOURNAL OF PHARMACOLOGY (2003)
Predicting the clinical status of human breast cancer by using gene expression profiles
M West et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)